AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2017
Feb 16, 2017
30339_dirs_2017-02-16_6b32af32-2441-4e2c-8e2a-08c04d5cd1c2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2017-02-14
Reporting Person: Malone Daniel (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-14 | Common Stock | A | 943.00 | $86.93 | Acquired | 27726.8866 | Direct |
| 2017-02-14 | Common Stock | A | 1272.00 | $86.93 | Acquired | 28998.8866 | Direct |
Footnotes
F1: Shares represent the portion of the Performance Share Unit Award granted in 2014 that have vested for period 13.
F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
F3: Bonus and incentive shares granted on 02/14/2017.
More from WEST PHARMACEUTICAL SERVICES INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 12